Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Cancer Discovery|June 20, 2013
Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and deathChristopher M Heaphy, Ghil Suk Yoon, Sarah B Peskoe, et al.
Thyroid : Official Journal of the American Thyroid Association|September 26, 2008
Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasmsYongchun Wang, Jeanne Kowalski, Hua-Ling Tsai, et al.
The American Journal of Pathology|November 5, 2002
Telomere shortening is nearly universal in pancreatic intraepithelial neoplasiaN Tjarda van Heek, Alan K Meeker, Scott E Kern, et al.
The Journal of Pathology|April 19, 2021
Downregulation of 5-hydroxymethylcytosine is an early event in pancreatic tumorigenesisKohei Fujikura, Zainab I Alruwaii, Michael C Haffner, et al.
The Journal of Pathology|September 10, 2017
MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancerJavier A Baena-Del Valle, Qizhi Zheng, David M Esopi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor SurvivalJoo Young Kim, Jacqueline A Brosnan-Cashman, Soyeon An, et al.
Nature Reviews. Urology|November 1, 2023
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancerJoakin O Mori, Isra Elhussin, W Nathaniel Brennen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 21, 2015
Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal CellsCorinne E Joshu, Sarah B Peskoe, Christopher M Heaphy, et al.
Molecular Cancer Research : MCR|October 16, 2019
Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer CellsMindy K Graham, Jiyoung Kim, Joseph Da, et al.
The Journal of Clinical Investigation|October 19, 2013
Tracking the clonal origin of lethal prostate cancerMichael C Haffner, Timothy Mosbruger, David M Esopi, et al.
Pageof 13